CRAI vs EXPO

For growth investors, CRA International, Inc.

(CRAI) is the stronger pick with 9. 3% revenue growth year-over-year, versus 4. 2% for Exponent, Inc. (EXPO). CRA International, Inc. (CRAI) offers the better valuation at 17. 1x trailing P/E (16. 9x forward), making it the more compelling value choice. Analysts rate CRA International, Inc. (CRAI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CRA International, Inc.

(CRAI) is the cheapest at 17. 1x versus Exponent, Inc. at 30. 6x. On forward P/E, CRA International, Inc. is actually cheaper at 16. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CRA International, Inc. wins at 0. 78x versus Exponent, Inc. 's 5. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, CRA International, Inc.

(CRAI) delivered a total return of +71. 5%, compared to -28. 5% for Exponent, Inc. (EXPO). Over 10 years, the gap is even starker: CRAI returned +550. 5% versus EXPO's +186. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CRA International, Inc.

(CRAI) is the lower-risk stock at 0. 73β versus Exponent, Inc. 's 0. 89β — meaning EXPO is approximately 21% more volatile than CRAI relative to the S&P 500. On balance sheet safety, Exponent, Inc. (EXPO) carries a lower debt/equity ratio of 21% versus 60% for CRA International, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), CRA International, Inc.

(CRAI) is pulling ahead at 9. 3% versus 4. 2% for Exponent, Inc. (EXPO). On earnings-per-share growth, the picture is similar: CRA International, Inc. grew EPS 20. 8% year-over-year, compared to -1. 9% for Exponent, Inc.. Over a 3-year CAGR, CRAI leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Exponent, Inc.

(EXPO) is the more profitable company, earning 18. 2% net margin versus 7. 3% for CRA International, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 11. 1% for CRAI. At the gross margin level — before operating expenses — CRAI leads at 29. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CRA International, Inc. (CRAI) is the more undervalued stock at a PEG of 0. 78x versus Exponent, Inc. 's 5. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, CRA International, Inc. (CRAI) trades at 16. 9x forward P/E versus 30. 9x for Exponent, Inc. — 14. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRAI: 39. 4% to $194. 00.

All stocks in this comparison pay dividends.

Exponent, Inc. (EXPO) offers the highest yield at 1. 9%, versus 1. 5% for CRA International, Inc. (CRAI).

For long-horizon retirement investors, CRA International, Inc.

(CRAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), 1. 5% yield, +550. 5% 10Y return). Both have compounded well over 10 years (CRAI: +550. 5%, EXPO: +186. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CRAI is a small-cap deep-value stock; EXPO is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.